Abstract
Most behavioral adverse effects of medications do not differ in quality from similar behaviors that may be present when a child is free of medication. Cognitive adverse effects that are demonstrated with specialized testing may not be apparent in the classroom or when testing with routine educational batteries. Some impairments demonstrated in the laboratory cannot be corroborated during real-life activities, such as operating a motor vehicle. The literature may report adverse events that occur following the administration of a single dose of medication to a healthy volunteer during a drug trial study. The same adverse event may not occur during long-term administration of the same drug to a patient. The medical literature does not always clarify whether problems are life-threatening major medical events, transient effects that will dissipate rather quickly, or “nuisance” effects limited to subjective somatic complaints that are of no demonstrable consequence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aminoff, M. J., Marshall, J., Smith, E., & Wyke, M. (1974). Cognitive function in patients on lithium therapy. British Journal of Psychiatry, 125, 109–112.
Anderson, L. T., Campbell, M., Grega, D. M., Perry, R., Small, A. M., & Green, W. H. (1984). Haloperidol in the treatment of infantile autism: Effects upon learning and behavioral symptoms. American Journal of Psychiatry, 141, 1195–1202.
Behrle, F. C., Elkin, M. T., & Laybourne, P. C. (1956). Evaluation of a conditioning device in the treatment of nocturnal enuresis. Pediatrics, 17, 849–856.
Biederman, J., Baldessarini, R. J., Goldblatt, A., Lapey, K. A., Doyle, A., & Hesslein, P. (1993). A naturalistic study of 24-hour electrocardiographic recordings and echocardio-graphic findings in children and adolescents treated with desipramine. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 805–813.
Block, R. I., DeVoe, M., Stanley, B., Stanley, M., & Pomara, N. (1985). Memory performance in individuals with primary degenerative dementia: Its similarity to diazepam-induced impairments. Experimental Aging Research, 11, 151–155.
Bonne, H. L., Etevenon, P., Benyacoub, J., & Slowen, P. (1981). Intellectual efficiency in manic-depressive patients treated with lithium. Acta Psychiatrica Scandinavica, 64, 423–430.
Braff, D. L., & Saccuzzo, D. P. (1982). Effect of antipsychotic medication on speed of information processing in schizophrenic patients. American Journal of Psychiatry, 139, 1127–1130.
Brumback, R. A., & Staton, R. D. (1980). Neuropsychological study of children during and after remission and endogenous depressive episodes. Perceptual and Motor Skills, 50, 1163–1167.
Campbell, M., Small, A. M., Green, W. H., Jennings, M. A., Perry, R., Bennett, W. G., Pedron-Gayol, M., & Anderson, L. (1982). Lithium and haloperidol in hospitalized aggressive children. Psychopharmacology Bulletin, 18, 126–130.
Christodoulous, G. N., Kokkevi, A., Lykouras, E. P., Stefanis, C. N., & Papadimitriou, G. N. (1981). Effects of lithium on memory. American Journal of Psychiatry, 18, 847–848.
Cleghorn, J. M., Kaplan, R. D., Szechtman, B., Szechtman, H., & Brown, G. M. (1990). Neuroleptic drug effects on cognitive function in schizophrenia. Schizophrenia Research, 3, 211–219.
Cole, S. O. (1986). Effects of benzodiazepines on acquisition and performance: A critical assessment. Neuroscience and Biobehavioral Reviews, 10, 265–272.
deGier, J. J., Hart, B. J., Nelemans, F. A., & Bergman, H. (1981). Psychomotor performance and real driving performance of outpatients receiving diazepam. Psychopharmacology, 73, 340–344.
Department of Health and Human Services, United States Government. (1982). Use of approved drugs for unlabeled indications. FDA Drug Bulletin, 12, 4–5.
Dietch, J. T., and Jennings, R. K. (1988). Aggressive dyscontrol in patients treated with benzodiazepines. Journal of Clinical Psychiatry, 49, 184–188.
DiMascio, A., Giller, D. R., and Shader, R. I. (1968). Behavioral toxicity of psychotropic drugs: III. Effects on perceptual and cognitive functions. Connecticut Medicine, 32, 771–775.
DiMascio, A., Heninger, G., and Klerman, G. L. (1964). Psychopharmacology of imipramine and desipramine: A comparative study of their effects in normal males. Psychopharmacologia, 5, 361–371.
Dugas, J. E. (1977). Mood elevation and medication. Diseases of the Nervous System, 38, 958.
Eitan, N., Levin, Y., Ben-Artzi, E., Levy, A., and Neumann, M. (1992). Effects of antipsychotic drugs on memory functions of schizophrenic patients. Acta Psychiatrica Scandinavica, 85, 74–76.
Fayen, M., Goldman, M. B., Moulthrop, M. A., and Luchins, D. J. (1988). Differential memory function with dopaminergic versus anticholinergic treatment of drug-induced extrapyramidal symptoms. American Journal of Psychiatry, 145, 483–486.
Ferguson, H. B., and Simeon, J. G. (1984). Evaluating drug effects on children’s cognitive functioning. Progress in Neuropsychopharmacology and Biological Psychiatry, 8, 683–686.
Gardos, G. (1980). Disinhibition of behavior by antianxiety drugs. Psychosomatics, 21, 1025–1026.
Ghoneim, M. M., and Mewaldt, S. P. (1990). Benzodiazepines and human memory: A review. Anesthesiology, 72, 926–938.
Gittelman-Klein, R., and Klein, D. F. (1971). Controlled imipramine treatment of school phobia. Archives of General Psychiatry, 25, 204–207.
Gittelman-Klein, R., and Klein, D. F. (1973). School phobia: Diagnostic considerations in the light of imipramine effect. Journal of Nervous and Mental Disease, 156, 199–215.
Glass, R. M., Uhlenhuth, E. H., Harrel, F. W., Matuzas, W., and Fischman, M. W. (1981). Cognitive dysfunction and imipramine in outpatient depressives. Archives of General Psychiatry, 38, 1048–1051.
Glass, R. M., Uhlenhuth, E. H., and Weinreb, H. (1978). Imipramine-reversible cognitive deficit in outpatient depressives. Psychopharmacology Bulletin, 14, 10–11.
Golombok, S., Moodley, P., and Ladner, M. (1988). Cognitive impairment in long term benzodiazepine users. Psychological Medicine, 18, 365–374.
Gotestam, K. G., andAnderson, B. E. (1978). Subjective effects and vigilance after diazepam and oxazepam in normal subjects. Acta Psychiatrica Scandinavica, 274 (Suppl.), 117–128.
Greenberg, H. R., and Carrillo, C. (1968). Thioridazine-induced inhibition of masturbatory ejaculation in an adolescent. American Journal of Psychiatry, 124, 151–153.
Guatrieri, C. T., and Patterson, D. R. (1986). Neuroleptic-induced tics in two hyperactive children. American Journal of Psychiatry, 143, 1176–1177.
Healey, M., Pickens, R., Meisch, R., and McKenna, T. (1983). Effects of clorazepate, diazepam, lorazepam and placebo on human memory. Journal of Clinical Psychiatry, 44, 436–439.
Helper, M. M., Wilcott, R. C., and Garfield, S. L. (1963). Effects of chlorpromazine on learning and related processes in emotionally disturbed children. Journal of Consulting Psychology, 27, 1–9.
Henry, G. M., Weingartner, H., and Murphy, D. L. (1973). Influence of affective states and psychoactive drugs on verbal learning and memory. American Journal of Psychiatry, 130, 966–971.
Hobi, V., Gastpar, M., Gastpar, G., Gilsdorf, U., Kielholz, P., and Schwarz, E. (1982). Driving ability of depressive patients under antidepressants. Journal of International Medical Research, 10, 65–81.
Huey, L. Y., Janowsky, D. S., Judd, L. L., Abrams, A., Parker, D., and Clopton, P. (1981). Effects of lithium carbonate on methylphenidate-induced mood, behavior and cognitive process. Psychopharmacology, 73, 161–164.
Israel, M., and Beaudry, P. (1988). Carbamazepine in psychiatry: A review. Canadian Journal of Psychiatry, 33, 577–584.
Jani, N. N., and Wise, T. N. (1988). Antidepressants and inhibited female orgasm: A literature review. Journal of Sex and Marital Therapy, 14, 279–284.
Judd, L. L., Hubbard, B., Janowsky, D. S., Huey, L. Y., and Takahashi, K. I. (1977). The effect of lithium carbonate on the cognitive functions of normal subjects. Archives of General Psychiatry, 34, 355–357.
Kardash, S., Hillman, E. S., and Werry, J. (1968). Efficacy of imipramine in childhood enuresis: A double-blind control study with placebo. Journal of the Canadian Medical Association, 99, 263–266.
Keeler, M. H., Prange, A. J., and Reifler, C. B. (1966). Effects of imipramine and thioridazine on set and action. Diseases of the Nervous System, 27, 798–802.
King, D. J. (1990). The effect of neuroleptics on cognitive and psychomotor function. British Journal of Psychiatry, 157, 799–811.
Koelega, H. S. (1989). Benzodiazepine and vigilance perfor- mance: A review. Psychopharmacology, 98, 145–156.
Kornetsky, C., Williams, J. E. G., and Bird, M. (1990). Attentional and motivational effects of psychoactive drugs. NIDA Research Monograph, 97, 177–192.
Kupietz, S. S., and Balka, E. B. (1976). Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy. Psychopharmacology, 50, 29–33.
Kusumo, K. S., and Vaughn, M. (1977). Effects of lithium salts on memory. British Journal of Psychiatry, 131, 453–457.
Lamping, D. L., Spring, B., and Gelenberg, A. J. (1984). Effects of two antidepressants on memory performance in depressed outpatients: A double blind study. Psychopharmacology, 84, 254–261.
Legg, J. F., and Stiff, M. P. (1976). Drug-related test patterns of de- pressed patients. Psychopharmacology, 50, 205–210.
Lister, R. G. (1985). The amnestic actions of benzodiazepines in man. Neuroscience and Biobehavioral Reviews, 9, 87–94.
Livingston, R. L., Zucker, D. K., Isenberg, K., and Wetzel, R. D. (1983). Tricyclic antidepressants and delirium. Journal of Clinical Psychiatry, 44, 173–176.
Lucki, I., Rickels, K., Giesecke, M. A., and Geller, A. (1987). Differential effects of the anxiolytic drugs, diazepam and buspirone, on memory function. British Journal of Clinical Pharmacology, 23, 207–211.
Marusarz, T. Z., Wolpert, E. A., and Koh, S. D. (1981). Memory processing with lithium carbonate. Journal of Clinical Psychiatry, 42, 190–192.
Meador-Woodruff, J. H., Akil, M., Wisner-Carlson, R., and Grunhaus, L. (1988). Behavioral, and cognitive toxicity related to elevated plasma tricyclic antidepressant levels. Journal of Clinical Psychopharmacology, 8, 28–32.
Medical Economics. (1995). Physicians’ desk reference. Montvale, NJ: Author.
Miller, N. S., and Gold, M. S. (1990). Benzodiazepine tolerance, dependence, abuse and addiction. Journal of Psychoactive Drugs, 22, 23–33.
Murphy, D. L. (1977). The behavioral toxicity of monoamine oxidase-inhibiting antidepressants. Advances in Pharmacology and Chemotherapy, 14, 71–105.
Petrie, W. M. (1980). Sexual effects of antidepressants and psychomotor stimulant drugs. Modern Problems of Pharmacopsychiatry, 15, 77–90.
Pishkin, V., Fishkin, S. M., Shurley, J. T., Lawrence, B. E., and Lovallo, W. R. (1978). Cognitive and psychophysiologie response to doxepin and chlordiazepoxide. Comprehensive Psychiatry, 19, 171–178.
Platt, J. E., Campbell, M., Green, W. H., and Grega, D. M. (1984). Cognitive effects of lithium carbonate and haloperidol in treatment-resistant aggressive children. Archives of General Psychiatry, 41, 657–662.
Pleak, R. R., Birmaher, B., Gavrilescu, A., Abichandani, C., and Williams, D. T. (1988). Mania and neuropsychiatrie excitation following carbamazepine. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 500–503.
Quinn, P. O., and Rapoport, J. L. (1975). One year follow-up of hyperactive boys treated with imipramine or methylphenidate. American Journal of Psychiatry, 132, 241–245.
Rapoport, J. (1965). Childhood behavior and learning problems treated with imipramine. International Journal of Psychiatry, 1, 635–642.
Rapoport, J. L., Quinn, P. O., Bradbard, G., Riddle, K. D., and Brooks, E. (1974). Imipramine and methylphenidate treatments of hyperactive boys. Archives of General Psychiatry, 30, 789–793.
Riddle, M. A., Nelson, J. C., Kleinman, C. S., Rasmusson, A., Leckman, J. F., King, R. A., and Cohen, D. J. (1991). Sudden death in children receiving norpramin: A review of three reported cases and commentary. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 845–846.
Rosenbaum, J. F., and Pollack, M. H. (1988). Anhedonic ejaculation with desipramine. International Journal of Psychiatry in Medicine, 18, 85–88.
Ross, R. J., Smallberg, S., and Weingartner, H. (1984). The effects of desmethylimipramine on cognitive function in healthy subjects. Psychiatry Research, 12, 89–97.
Segraves, R. T. (1988). Psychiatric drugs and inhibited female orgasm. Journal of Sex and Marital Therapy, 14, 202–207.
Shay, J., Sanchez, L. E., Cueva, J. E., Armenteros, J. L., Overall, J. E., and Campbell, M. (1993). Neuroleptic-related dyskinesias and stereotypies in autistic children: Videotaped ratings. Psychopharmacology Bulletin, 29, 359–363.
Shen, W. W., and Lindbergh, S. S. (1990). Inhibited female orgasm resulting from psychotropic drugs: A five year updated clinical review. Journal of Reproductive Medicine, 37, 11–14.
Silva, R. R., Malone, R. P., Anderson, L. T., Shay, J., and Campbell, M. (1993). Haloperidol withdrawal and weight changes in autistic children. Psychopharmacology Bulletin, 29, 287–291.
Sliwa, J. A., and Lis, S. (1993). Drug-induced dysphagia. Archives of Physical Medicine and Rehabilitation, 74, 445–447.
Spiegel, D. E., and Keith-Spiegel, P. (1967). The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients. The Journal of Nervous and Mental Disease, 144, 111–116.
Sprague, R. L., Barnes, K. R., and Werry, J. S. (1970). Methylphenidate and thioridazine: Learning, reaction time, activity and classroom behavior in disturbed children. American Journal of Orthopsychiatry, 40, 615–628.
Squire, L. R., Judd, L. L., Janowsky, D. S., and Huey, L. Y. (1980). Effects of lithium carbonate on memory and other cognitive functions.AmericanJournalofPsychiatry, 137, 1042–1046.
Staton, R. D., Wilson, H., and Brumback, R. A. (1981). Cognitive improvement associated with tricyclic antidepressant treatment of childhood major depressive illness. Perceptual and Motor Skills, 53, 219–234.
Stenberg, A., and Lackgren, G. (1994). Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics, 94, 841–846.
Sternberg, D. E., and Jarvik, M. E. (1976). Memory functions in depression. Archives of General Psychiatry, 33, 219–224.
Strauss, W. H., and Kleiser, E. (1990). Cognitive disturbances in neuroleptic therapy. Acta Psychiatrica Scandinavica, 82 (Suppl. 358), 56–57.
Strauss, W. H., Kleiser, E., and Leuthcke, H. (1988). Dyscognitive syndromes in neuroleptic therapy. Pharmacopsychiatry, 21, 298–299.
Sweeney, J. A., Keilp, J. G., Haas, G. L., Hill, J., and Weiden, P. J. (1991). Relationships between medication treatments and neuropsychological test performance in schizophrenia. Psychiatry Research, 37, 297–308.
Thienhaus, O. J., Allen, A., Bennett, J. A., Chopra, Y. M., & Zemlan, F. P. (1990). Anticholinergic serum levels and cognitive performance. European Archives of Psychiatry and Clinical Neuroscience, 240, 28–33.
Thompson, P. J. (1991). Antidepressants and memory: A review. Human Psychopharmacology, 6, 79–90.
Thompson, P. J., & Trimble, M. R. (1982). Non-MAOI antidepressant drugs and cognitive functions: A review. Psychological Medicine, 12, 539–548.
Tingelstad, J. B. (1991). The cardiotoxicity of the tricyclics. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 845–846.
Weise, C. C., O’Reilly, R. P., & Hesbacher, P. (1972). Perphenazine-amitriptyline in neurotic underachieving students: A controlled study. Diseases of the Nervous System, 33, 318–325.
Weiss, A. A., Robinson, S., & Dasberg, H. (1973). Changes in mental functioning accompanying antipsychotic drug therapy. Annals of Psychiatry and Related Disciplines, 11, 134–140.
Werry, J. S., Aman, M. G., & Diamond, E. (1979). Imipramine and methylphenidate in hyperactive children. Journal of Child Psychology and Psychiatry, 21, 27–35.
Werry, J. S., Dowrick, R. W., Lampen, E. L., & Vamos, M. J. (1975). Imipramine in enuresis-Psychological and physiological effect. Journal of Child Psychology and Psychiatry, 16, 289–299.
Werry, J. S., Weiss, G., Douglas, V., & Martin, M. A. (1966). Studies on the hyperactive child: The effect of chlorpromazine upon behavior and learning ability. Journal of the American Academy of Child Psychiatry, 5, 292–312.
Wilens, T. E., Biederman, J., Spencer, T., & Geist, D. E. (1993). A retrospective study of serum level and electrocardio-graphic effects of nortriptyline in children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 270–277.
Wittenborn, J. R. (1988). Assessment of the effect of drugs on memory. Psychopharmacology Series, 6, 67–78.
Zimmermann-Tansella, C. (1984). Psychological performance of normal subjects on tasks commonly used in evaluation of anxiolytic drugs. Perceptual and Motor Skills, 58, 803–810.
Zisook, S., & DeVaul, R. (1977). Adverse behavioral effects of benzodiazepines. The Journal of Family Practice, 5, 963–966.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cepeda, M.L. (1997). Nonstimulant Psychotropic Medication. In: Reynolds, C.R., Fletcher-Janzen, E. (eds) Handbook of Clinical Child Neuropsychology. Critical Issues in Neuropsychology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5351-6_28
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5351-6_28
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5353-0
Online ISBN: 978-1-4757-5351-6
eBook Packages: Springer Book Archive